18 June 2025 - National health care institute Zorginstituut Nederland has scrapped several cancer inhibiting drugs from the basic health ...
8 July 2025 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
10 July 2025 - NICE has published final evidence-based recommendations on the use of zanubrutinib for the treatment of adults ...
10 July 2025 - Submission of marketing authorization application to the EMA seeking approval for investigational low dose gadoquatrane for contrast-enhanced ...
10 July 2025 - New indication based on results of RATIONALE-309 study demonstrating statistically significant improvement in progression-free survival. ...
11 July 2025 - New PDUFA action date of 13 December 2025. ...
11 July 2025 - complete response letter cited specific chemistry, manufacturing and controls related observations that are resolvable. ...
10 July 2025 - Company planning to initiate Phase 3 program. ...
9 July 2025 - Eli Lilly Canada is pleased to announce that Zepbound KwikPen (tirzepatide injection) is now available in Canada, ...
8 July 2025 - Norgine is pleased to announce that Swissmedic has approved the registration of Ifinwil (eflornithine) as monotherapy ...
9 July 2025 - Trethera announced today that the US FDA has granted fast track designation for its novel drug, TRE-515, ...
11 July 2025 - Capricor plans to resubmit its BLA to include data from the ongoing Phase 3 HOPE-3 trial in ...
8 July 2025 - The MHRA has today become the first regulator in the world to approve elinzanetant (Lynkuet) for the ...
9 July 2025 - Donald Trump’s move to ramp up tariffs on medicines and copper has sparked alarm among government ...
9 July 2025 - The newly recommended dosing schedule significantly lowered ARIA-E rates compared to the original dosing schedule, adding ...
8 July 2025 - Novo Nordisk today announced the submission of an application to the EMA for approval of a new, ...